UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

Recruiting N/A Interventional Study
Acute Kidney Injury
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
6,046 (estimated)
Sponsor
University of Alberta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Nearly one in ten people who are hospitalized in Canada develop a complication with sudden loss of kidney function, called acute kidney injury (AKI). AKI may lead to other severe health problems after discharge home, such as kidney failure requiring dialysis treatment, heart failure, heart attacks, stroke, and even premature death. Discharge from hospital to home can be a difficult transition wher…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: (all of) * Age ≥ 18 years old * Hospitalized at site using AHS EHR * Acute Kidney Injury (Stage 1-3) identified in hospital per KDIGO guideline criteria Exclusion Criteria: (any of) * Pre-hospitalization advanced CKD: eGFR\<30 mL/min/1.73m2 * Pre-hospitalization dialysis * V…
Contacts

Neesh Pannu

780 492 8519

npannu@ualberta.ca

CONTACT